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ABSTRACT 
PURPOSE: For gay and bisexual men (GBM), research suggests that familiarity with Pre-
Exposure Prophylaxis (PrEP) has been increasing since being approved by the U.S. FDA in 
2012. However, it is less clear how willingness to start using PrEP has changed over time. 
Likewise, some have expressed concerns regarding the potential for risk compensation (i.e., 
reduced condom use) were one to start PrEP; however, again, it is unclear how these may have 
been changing over time.  
METHODS: We conducted baseline and 12 month assessments with 158 highly sexually active 
HIV-negative GBM in NYC who were assessed between 2011 and 2014. We examined change 
over time both between participants (based on when they entered the study), as well as within 
each participant (over the 12 months of his involvement).   
RESULTS: Familiarity with PrEP increased over time (both between and within participants); 
however, willingness to take PrEP did not change (neither between nor within participants). Few 
men believed taking PrEP would cause their condomless anal sex (CAS) to increase and this did 
not change over time. However, a majority believed PrEP would increase temptation for CAS, 
and this did not change over time within participants. Sexual compulsivity (SC) symptomology 
was associated with higher willingness to take PrEP and perceiving that PrEP would increase 
one’s temptations for CAS. Furthermore, recent CAS was associated with greater willingness to 
take PrEP, a perception that PrEP would increase one’s likelihood to engage in CAS, and a 
perception that being on PrEP would increase one’s temptation for CAS. 
CONCLUSIONS:  Participants became more familiar with PrEP over time; however, 
willingness to start PrEP did not change, and this may serve as an opportunity for providers to 
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discuss PrEP with their patients. Higher risk men were interested in PrEP and pre-existing 
patterns of sexual behavior may be the primary determinant of CAS while on PrEP.  
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Introduction 
Gay and bisexual men (GBM) continue to be disproportionately affected by HIV in the 
United States, making up 84% of new infections among men.
1
 In July 2012, the United States 
Food and Drug Administration (FDA) approved once-daily Truvada (emtricitabine/tenofovir 
disproxil fumarate) for use as Pre-Exposure Prophalyxis (PrEP) to prevent HIV transmission to 
HIV-negative individuals. It has been recommended by both the Centers for Disease Control and 
Prevention (CDC) and the World Health Organization (WHO).
2,3
 Among GBM, evidence from 
several studies suggests that familiarity with PrEP has been increasing over time from reported 
ranges of 11% in 2010-2011
4
 to 54% in 2014.
5
 However, it is less clear how willingness to start 
PrEP has changed over time. Research addressing willingness to start PrEP has varied from 28-
80% with most studies reporting 50% or higher.
4
 Anecdotal data suggest that there are multiple 
barriers to beginning PrEP including stigma attached to using PrEP,
6
 fears around side effects 
and potential drug resistance to future forms of HIV biomedical prevention.
7
  
 Likewise, some researchers and popular media outlets have expressed concerns regarding 
the potential for risk compensation via reduced condom use (i.e., biological risks are decreased 
due to PrEP and so condom use decreases).
8
  A PrEP demonstration project from three cities 
(San Francisco, Miami, and Washington D.C.) conducted between 2012 and 2015 that followed 
participants for 48 weeks found that the average number of anal sex partners declined during 
follow-up from 10.9 to 9.3, whereas the proportion engaging in condomless receptive anal sex 
remained stable at 66%.
9
 Although STI incidence was high (90 infections per 100 person-years), 
it did not increase over time. Only two individuals contracted HIV, both of whom had plasma 
levels of PrEP consistent with fewer than two doses per week at seroconversion.
10
 A recent San 
Francisco study of men on PrEP reported no new HIV infections over a 2.5 year period, while 
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more than half of participants had contracted an STI, which suggests low rates of condom use 
while on PrEP, though rates of condom use prior to beginning PrEP were not reported.
11
   
To provide insights into changes in familiarity with PrEP as well as willingness to start 
PrEP, we conducted baseline and month 12 assessments with highly sexually active gay and 
bisexual men assessed between 2011 and 2014. At both time points we assessed for familiarity 
with PrEP and willingness to start PrEP. In addition, we assessed for perceived effect of PrEP on 
condomless anal sex (CAS) as well as temptation for CAS.   
Method 
Analyses for this article were conducted on data from Pillow Talk, a longitudinal study of 
highly sexually active (i.e., ≥ 9 male partners in 90 days) gay and bisexual men in New York 
City (NYC).
12
 Participants were recruited using a combination of strategies: (1) respondent-
driven sampling; (2) Internet-based advertisements on social and sexual networking websites; (3) 
email blasts through NYC gay sex party listservs; and (4), active recruitment in  NYC venues 
such as gay bars/clubs, concentrated gay neighborhoods, and ongoing gay community events. 
Enrollment began in February 2011 and closed in June 2013. Participants were followed 
for a period of 12 months. Data for this article were taken from the baseline and 12 month visits 
(the last participant completed his 12 month assessment in June 2014). The project enrolled both 
HIV-negative and HIV-positive men, though the analyses for this article were limited to HIV-
negative men. Of the 376 men who enrolled in the project, 207 (55.2%) were confirmed to be 
HIV-negative with a rapid HIV antibody test during their baseline assessment—two of these 
participants tested HIV-positive at their 12-month assessment and were excluded. One of these 
men was missing necessary data at baseline, 42 individuals did not return for their 12-month 
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assessment, and four were missing necessary data at the 12-month assessment. Thus, analyses 
focused on a sample of 158 participants.  
Participants and Procedures 
To be eligible, participants had to be at least 18 years of age, biologically male and self-
identified as male, report nine or more male sexual partners in the prior 90 days, self-identified as 
gay, bisexual, or some other non-heterosexual identity (e.g., queer), and have access to the 
Internet. Participants were emailed a link to an Internet-based computer-assisted self-interview 
(CASI), which included informed consent procedures. Men completed this one-hour online 
survey at home followed by an in-person baseline appointment and the same procedures were 
followed for the 12-month assessment. In-person assessments included a structured timeline 
follow-back (TLFB) interview in which a calendar is used to recall one’s daily sexual behavior 
and substance use.
13
 Final eligibility and enrollment was confirmed during the in-person 
appointment. All procedures were reviewed and approved by the City University of New York 
Institutional Review Board.  
Measures 
Measures used for this article were taken from the baseline and 12-month assessment. 
Using a computer-assisted survey, participants reported demographic characteristics, including 
sexual identity, age, race/ethnicity, education, and relationship status. Participants also 
completed the 10-item Sexual Compulsivity Scale (SCS; α = 0.91).14,15 The SCS has been shown 
to have high reliability and validity across multiple studies.
16,17 
 A score of 24 was used as a 
cutoff indicative of experiencing problematic levels of sexual compulsivity.
18-21
 
 At baseline and month 12, participants were presented with the following brief summary 
of PrEP:
22
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“PrEP (pre-exposure prophylaxis) is a new biochemical strategy to prevent HIV 
infection. PrEP involves HIV-negative guys taking anti-HIV medications (for example, 
Truvada) once a day, every day to reduce the likelihood of HIV infection if they were 
exposed to the virus. The first clinical trial of PrEP indicated that it reduced the 
likelihood of HIV infection when used in combination with other preventative methods, 
such as condoms.”  
Participants then responded to a series of single-item questions regarding PrEP. 
Familiarity with PrEP. Participants were asked how familiar they were with PrEP (I’ve 
never heard of it before today; I’ve heard about it, but I don’t really know what it was; I know a 
little bit about it; I know a fair amount about it; I know a lot about it). Those indicating they 
knew a fair amount or a lot were coded as being familiar with PrEP (0 = no, 1 = yes).  
Willingness to take PrEP. Participants were asked how likely they would be to take 
PrEP if it were at least 40% effective and offered to them for free (“definitely,” “probably,” 
“might,” “probably not,” “definitely not”). Those who said they would probably or definitely 
take it were coded as being likely to take PrEP (0 = no, 1 = yes). 
Likelihood of engaging in CAS. Men were also asked how taking PrEP would influence 
their likelihood to engage in condomless anal sex (“significantly more likely,” “somewhat more 
likely,” “would not change,” “somewhat less likely,” “significantly less likely.”). The variable 
was dichotomized to reflect those who responded that PrEP would make them somewhat or 
significantly more likely to engage in CAS (0 = no, 1 = yes).  
Temptation to engage in CAS. Men were asked “How do you think taking PrEP would 
impact your temptation to have sex without condoms?” with Likert-type responses on a 7-point 
scale. The anchor points were -3 = “much less tempted,” 0 = “no impact,” and +3 = “much more 
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tempted.” This variable was dichotomized with those indicating 1 through 3 coded as having 
increased temptation for CAS (0 = no, 1 = yes).  
 During the TLFB interview, we collected data on CAS with any male partners in the prior 
6 weeks (42 days), dichotomized 1 = yes, 0 = no. In addition, we collected data on instances of 
club drug use (ketamine, MDMA/ecstasy, GHB, cocaine, crystal methamphetamine) in the past 6 
weeks, dichotomized 1 = yes, 0 = no.  
Analytic Plan 
We calculated the month of enrollment during which each participant joined (0 through 
27) and created a dichotomous variable indicating the type of visit (baseline = 0, 12-month 
follow-up = 1). We created a dichotomous variable indicating whether or not each visit occurred 
after the FDA approval of PrEP on July 16, 2012. 
We conducted multilevel modeling examining the effect of between-person enrollment 
month (0 through 27) and within-person visit type (Baseline vs. 12 month) on PrEP familiarity, 
willingness to take PrEP, and perceived influence of PrEP on likelihood and temptation to 
engage in CAS. All models were adjusted for time-invarying covariates (age, White race, sexual 
identity, and college education or higher which were all measured at baseline), as well as three 
time-varying covariates (relationship status, whether or not the FDA had yet approved PrEP (i.e., 
data collected before and after July 2012), and whether or not the participant had engaged in any 
CAS with a male partner at each assessment point). Throughout the results we distinguish 
between-person (i.e., time invariant) versus within-person (i.e., time-varying) effects within the 
multilevel models. In reference to the effect of time, the between-person effect references the 
time when individuals began the study and can be interpreted as the change in the odds of the 
outcome for an individual who started the study later than another individual. The within-person 
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effect of time compares each individual’s odds of the outcome after 12 months of being enrolled 
in the study compared to his own odds at baseline. 
Results 
 As seen in Table 1, the sample was diverse at baseline with regards to race/ethnicity and 
educational attainment, whereas a majority of the sample was gay-identified and single. At 
baseline, 22.8% were familiar with PrEP, 46.8% expressed willingness to take PrEP, 25.3% 
believed PrEP would increase their likelihood to engage in CAS, and 58.2% believed PrEP 
would increase their temptation to engage in CAS. By the 12-month assessment, the numbers 
familiar with PrEP and who believed their likelihood of CAS would increase on PrEP had both 
grown somewhat, whereas the numbers who were willing to take PrEP and who believed their 
temptation for CAS would increase on PrEP had slightly declined. More than half of the sample 
had engaged in CAS at baseline and this declined to about half at follow-up, whereas 
approximately one-quarter had used club drugs at baseline and this increased to nearly 30%. It is 
worth noting that there was a decline in the number of male partners men reported from baseline 
to follow-up as well. 
After adjusting for both demographic and behavioral characteristics in the model, the 
odds of being familiar with PrEP increased significantly between participants by 10% per month 
from the beginning to the end of enrollment but not within participants from baseline to follow-
up (see Table 2).. This suggests that individuals who started the study later had greater 
familiarity with PrEP than individuals who started the study earlier, but each individual’s 
familiarity was unchanged over the 12 months he was enrolled. The adjusted odds of being 
willing to take PrEP, perceiving that being on PrEP would increase the likelihood of engaging in 
CAS, and perceiving that being on PrEP would increase temptation to engage in CAS all 
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remained stable both between and within participants over time. This suggests that individuals 
who started the study later were no different than individuals who started the study earlier and 
individuals, on average, did not change over the course of their enrollment.  
It is also worth noting the significant associations of covariates within the models. At the 
between-participant level, gay men had higher odds than bisexual men of being willing to take 
PrEP, men with at least a college degree had lower odds than men with less education of being 
willing to take PrEP, and White men had higher odds than non-White men of believing PrEP 
would increase their likelihood of engaging in CAS. At the within-person level, reporting club 
drug use during a visit was associated with higher odds of also reporting familiarity with PrEP 
during that visit. Reporting sexual compulsivity (SC) symptomology was associated with higher 
odds of reporting willingness to take PrEP as well as perceiving that PrEP would increase one’s 
temptations for CAS during the same visit. Furthermore, reporting CAS prior to a visit was 
associated with higher odds of reporting during the same visit a willingness to take PrEP, a 
perception that PrEP would increase one’s likelihood to engage in CAS, and a perception that 
being on PrEP would increase one’s temptation for CAS. 
Discussion 
 Pillow Talk was a study of highly sexually active gay and bisexual men—individuals 
who are excellent candidates for PrEP based on WHO and CDC criteria/guidance.
2,3,23
  Our data 
demonstrated that individuals who started the study later had higher familiarity with PrEP, 
though there was no increase in each individual’s level of familiarity over the year he was in the 
study. Willingness to take PrEP was the same regardless of when individuals began the study and 
also did not change within individuals over the course of their enrollment; however, it is 
important to note that nearly half of participants were willing to take PrEP if it was free.  It may 
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be that willingness to start PrEP is the result of relatively stable individual-level factors that are 
more resistant to change over time, such as not believing that one would be an appropriate 
candidate for PrEP
2
 or stigma attached to using PrEP,
8
 neither of which was measured in this 
study. The results of this study highlight the need to identify barriers to PrEP uptake amidst 
increasing familiarity.  
Few men believed taking PrEP would cause their CAS to increase and we did not find 
evidence that this changed over time. A majority of participants believed PrEP would increase 
temptation for CAS, but this also did not appear to change over time. These findings suggest the 
importance of investigating differences between temptation and likelihood as well as their impact 
on actual changes in CAS among men before and after they start PrEP. Furthermore, although 
risk compensation is of concern for STIs, it also remains important for researchers to both 
investigate and acknowledge the intrinsic benefits of CAS such as increased sexual pleasure and 
feelings of connectedness.
24,25
  Likewise, researchers must acknowledge the relative risks of STI 
transmission and treatment versus HIV transmission and treatment.  
The results of this study should be understood in light of their limitations. To be eligible 
for Pillow Talk, men had to report at least 9 male partners in the prior 90 days. This sample 
represents, by definition, a priority population for PrEP; however, these men do not represent all 
GBM. One strength of our study was the assessment of changes between baseline and 12 
months; however, we recognize that both a longer assessment window and/or more incremental 
assessment points would have benefited this study. It would be important to replicate this study 
today in light of emerging data highlighting consistently the effectiveness of PrEP in 
community-based settings.
9,11
 Furthermore, we acknowledge that by virtue of asking participants 
about PrEP we are in-fact exposing them to information about PrEP, and this may have 
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contributed to our findings regarding increased knowledge over time. We did not assess where or 
how participants were learning about PrEP, and thus cannot attest to the magnitude of test-retest 
effects attributable to this study. Enrollment for this study began before data on clinical trials 
regarding PrEP’s effectiveness were available. Thus, we used a conservative estimate of 40% 
effectiveness when describing PrEP to participants. This number was in line with initial data on 
PrEP’s effectiveness;26 however, early findings included individuals who were prescribed PrEP 
but did not have detectable levels of PrEP in their bloodstream (i.e., were not taking PrEP). We 
now know that PrEP is much more effective when taken as prescribed
11
 and this new-and-
emerging information will likely have a significant impact on men’s decisions to use PrEP today. 
In essence, were revised estimates of effectiveness presented to participants, we might have 
observed different values for both uptake as well as the perceived impact on CAS.  
We do not have data on reasons why individuals were unwilling to take PrEP and our 
findings indicate that enough individuals were unwilling to do so that further consideration is 
warranted, perhaps through qualitative methods like semi-structured interviews and/or focus 
groups. The results of this study concerned hypothetical PrEP initiation. As PrEP continues to 
diffuse as a new prevention strategy, it is important to continue to investigate how PrEP will 
affect both perceived and actual sexual behaviors of GBM. Our measure of temptation to have 
sex without condoms did not specify anal sex; however, we believe strongly that participants 
understood this to mean anal sex. Finally, sexual behavior decreased among participants in our 
study over time, and this was controlled for in our analyses, but we did not have data as to why 
behavior decreased. It may be that because frequency was so high at baseline we observed a 
statistical regression toward the mean. 
Conclusion 
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 Gay and bisexual men became more aware of PrEP as enrollment for Pillow Talk 
continued in time, and this may be largely a result of the recent growth of both traditional and 
social media campaigns to promote PrEP education and dissemination (e.g., 
myPrEPexperience.blogspot.com, whatisPrEP.org, PrEPforsex.org, #TruvadaWhore on Twitter 
and Facebook); however, the actual effect of PrEP promotion campaigns was not measured in 
this study. Nevertheless, in this study, willingness to use PrEP did not change over time. To what 
extent was stagnant willingness to start PrEP a result of combined concerns regarding 
effectiveness, access, side effects, and fear of stigma? The potential for risk compensation 
seemed low (and unchanged over time); however, participants’ temptation for CAS as a result of 
PrEP was high. Data gathered from men before and after starting PrEP are necessary to discern 
the actual impact of PrEP in real world settings, and we suggest that researchers weigh the 
intrinsic benefits associated with CAS in the event of risk compensation.   
With the expansion of PrEP uptake, some have expressed concerns regarding risk 
compensation; however, less is mentioned about behavioral disinhibition. Risk compensation 
could be conceptualized as between subjects differences in cognitions and attitudes that 
differentially predict engagement in CAS (e.g., level 2 predictor); whereas, behavioral 
disinhibition could be conceptualized as changes in behaviors on average over time (e.g., 
between and within subjects changes in outcomes over time). Our findings suggest a need to 
collect data on and assess for risk compensation as well as behavioral disinhibition.
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Table 1. 
Demographic and background characteristics of the sample (N = 158) 
 
Baseline 
 
12-Month 
  n %   n % 
Race/Ethnicity 
     Black 24 15.2 
 
-- -- 
Latino 19 12.0 
 
-- -- 
White 93 58.9 
 
-- -- 
Other/multiracial 22 13.9 
 
-- -- 
Sexual Orientation 
     Gay 132 83.5 
 
-- -- 
Bisexual 26 16.5 
 
-- -- 
Educational Attainment 
     Less than a bachelor's degree 46 29.2 
 
-- -- 
Bachelor's degree 62 39.2 
 
-- -- 
Graduate degree 50 31.6 
 
-- -- 
Relationship Status 
     Single 134 84.8 
 
114 72.2 
Partnered 24 15.2 
 
44 27.8 
Familiar with PrEP 
     No 122 77.2 
 
107 67.7 
Yes 36 22.8 
 
51 32.3 
Willing to take PrEP 
     No 84 53.2 
 
87 55.1 
Yes 74 46.8 
 
71 44.9 
Likelihood of CAS on PrEP 
     No 118 74.7 
 
113 71.5 
Yes 40 25.3 
 
45 28.5 
Temptation for CAS on PrEP 
     No 66 41.8 
 
77 48.7 
Yes 92 58.2 
 
81 51.3 
Any CAS 
     No 63 39.9 
 
78 49.4 
Yes 95 60.1 
 
80 50.6 
Any club drug use 
     No 118 74.7 
 
111 70.3 
Yes 40 25.3 
 
47 29.7 
      
 
M SD   M SD 
Age 34.8 12.2 
 
-- -- 
Number of male partners 12.2 8.2 
 
6.6 6.2 
Note. Race/ethnicity, sexual orientation, educational attainment, and age 
were assessed once and fixed over time. 
 
  
18 
 
Table 2. 
Longitudinal models examining predictors of PrEP-relevant factors 
 
PrEP Familiarity 
 
Willingness to Take PrEP 
  B AOR 95% CI   B AOR 95% CI 
Between-Participant Factors (Level 2) 
       Age 0.03 1.03 0.99, 1.06 
 
-0.01 0.99 0.97, 1.02 
White race (ref = non-White) -0.41 0.66 0.31, 1.44 
 
-0.06 0.94 0.50, 1.76 
Gay (ref = bisexual) 0.82 2.28 0.80, 6.45 
 
0.93 2.53* 1.11, 5.74 
College degree (ref = no) -0.26 0.77 0.34, 1.75 
 
-0.92 0.40** 0.21, 0.77 
Month of enrollment 0.10 1.10** 1.02, 1.19 
 
0.04 1.04 0.98, 1.10 
Within-Participant Factors (Level 1) 
       Partnered (ref = single) -0.36 0.70 0.30, 1.64 
 
-0.55 0.58 0.29, 1.17 
Club drug use (ref = no) 0.89 2.44* 1.12, 5.30 
 
0.11 1.12 0.59, 2.12 
SC symptomology (ref = no) -0.40 0.67 0.33, 1.37 
 
0.62 1.86* 1.04, 3.32 
FDA approved PrEP (ref = no) 0.32 1.37 0.47, 3.98 
 
-0.52 0.59 0.25, 1.42 
Any CAS reported (ref = no) 0.27 1.31 0.66, 2.61 
 
0.79 2.21** 1.25, 3.91 
12-month assessment (ref = baseline)
b
 0.48 1.61 0.78, 3.35 
 
0.35 1.42 0.73, 2.77 
        
 
Likelihood of CAS on PrEP 
 
Temptation for CAS on PrEP 
  B AOR 95% CI   B AOR 95% CI 
Between-Participant Factors (Level 2) 
       Age -0.02 0.98 0.95, 1.01 
 
-0.03 0.97 0.95, 1.00 
Gay (ref = bisexual) 0.39 1.47 0.57, 3.84 
 
0.39 1.47 0.59, 3.64 
White race (ref = non-White) 1.04 2.82** 1.33, 5.98 
 
0.42 1.53 0.75, 3.09 
College degree (ref = no) 0.21 1.23 0.57, 2.69 
 
0.73 2.08 0.99, 4.38 
Month of enrollment 0.03 1.03 0.96, 1.10 
 
0.03 1.03 0.97, 1.10 
Within-Participant Factors (Level 1) 
       Partnered (ref = single) -0.16 0.85 0.39, 1.83 
 
0.43 1.54 0.71, 3.32 
Club drug use (ref = no) 0.10 1.11 0.54, 2.29 
 
0.04 1.04 0.50, 2.14 
SC symptomology (ref = no) 0.30 1.35 0.69, 2.63 
 
0.84 2.32** 1.21, 4.44 
FDA approved PrEP (ref = no) -0.49 0.61 0.22, 1.69 
 
0.82 2.28 0.87, 5.95 
Any CAS reported (ref = no) 1.71 5.51*** 2.65, 11.46 
 
1.27 3.57*** 1.91, 6.66 
12-month assessment (ref = baseline)
b
 0.65 1.91 0.87, 4.18   -0.66 0.52 0.25, 1.07 
Note. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; a Between-person time was coded as the month of the participant's enrollment 
(0 through 27) which was mean centered and time invariant (i.e., constant for the same participant over time); 
b
 Within-
participant time was dichotomously coded as the month of the assessment (BL = 0, 12M = 1) and was time-varying (i.e., 
differed for the same participant over time). Age and month of enrollment were both mean centered. 
 
 
 
